Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
about
GD2-targeted immunotherapy and radioimmunotherapyRetargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody.Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsNew immunotherapeutic strategies for the treatment of neuroblastoma.Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2.Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibody.Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression systemStructure Based Refinement of a Humanized Monoclonal Antibody That Targets Tumor Antigen Disialoganglioside GD2.T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics.
P2860
Q34625339-A5834A0A-FE92-4005-B462-B0B61F20C7E3Q35152029-6E048C65-4147-478E-AD18-EE9D09BD2818Q37078941-F14A1C8E-63F0-443A-B796-C3A852662EE2Q38389316-D02B999E-2E10-4304-A7F0-3A3FC601043EQ38400420-61622973-8F12-4436-A4CF-AD16A0E2F0C7Q38916529-4AC677F3-DE03-4C00-A3FE-DA2079CDCD25Q41033228-324F6C0A-559D-4198-B9EF-03078DDE386CQ41590699-23C1BBBA-8AA3-485E-8A66-44E342B030C0Q41647084-E0175D26-D588-4D89-A8ED-1BCDAA28B560Q42079963-1F48E763-70C8-4C5F-B76D-BD3A399CB36CQ47570404-A69334B9-D8C4-4ED5-9B26-726436F8DA19
P2860
Structural design of disialoganglioside GD2 and CD3-bispecific antibodies to redirect T cells for tumor therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Structural design of disialoga ...... ect T cells for tumor therapy.
@en
Structural design of disialoga ...... ect T cells for tumor therapy.
@nl
type
label
Structural design of disialoga ...... ect T cells for tumor therapy.
@en
Structural design of disialoga ...... ect T cells for tumor therapy.
@nl
prefLabel
Structural design of disialoga ...... ect T cells for tumor therapy.
@en
Structural design of disialoga ...... ect T cells for tumor therapy.
@nl
P2093
P2860
P356
P1476
Structural design of disialoga ...... ect T cells for tumor therapy.
@en
P2093
Mahiuddin Ahmed
Ming Cheng
Nai-Kong V Cheung
P2860
P304
P356
10.1002/IJC.29007
P577
2014-06-19T00:00:00Z